Published in Neuroscience on February 14, 2009
Individual differences in acute pain-induced endogenous analgesia predict time to resolution of postoperative pain in the rat. Anesthesiology (2015) 1.52
Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain. J Pain Res (2011) 1.08
Modulation of physiological reflexes by pain: role of the locus coeruleus. Front Integr Neurosci (2012) 0.93
Depletion of endogenous noradrenaline does not prevent spinal cord plasticity following peripheral nerve injury. J Pain (2011) 0.92
Optoactivation of locus ceruleus neurons evokes bidirectional changes in thermal nociception in rats. J Neurosci (2014) 0.91
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. Neuropharmacology (2009) 0.91
Spinal inhibitory neurotransmission in neuropathic pain. Curr Pain Headache Rep (2009) 0.90
Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism. J Neurosci (2015) 0.83
Antinociception by motor cortex stimulation in the neuropathic rat: does the locus coeruleus play a role? Exp Brain Res (2009) 0.82
Activation of NK₁ receptors in the locus coeruleus induces analgesia through noradrenergic-mediated descending inhibition in a rat model of neuropathic pain. Br J Pharmacol (2012) 0.81
The Effect of Acute Intra Locus Coeruleus (LC) Microinfusion of Bupropion on Formalin-Induced Pain Behavior in Rat. Basic Clin Neurosci (2014) 0.80
The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain. Psychopharmacology (Berl) (2011) 0.79
Alterations in the cholinergic system of brain stem neurons in a mouse model of Rett syndrome. Am J Physiol Cell Physiol (2014) 0.79
Dysregulation of the descending pain system in temporomandibular disorders revealed by low-frequency sensory transcutaneous electrical nerve stimulation: a pupillometric study. PLoS One (2015) 0.77
GABA-A receptor activity in the noradrenergic locus coeruleus drives trigeminal neuropathic pain in the rat; contribution of NAα1 receptors in the medial prefrontal cortex. Neuroscience (2016) 0.76
Glial cell line-derived neurotrophic factor-mediated enhancement of noradrenergic descending inhibition in the locus coeruleus exerts prolonged analgesia in neuropathic pain. Br J Pharmacol (2015) 0.75
Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep. eNeuro (2016) 0.75
A possible role of the locus coeruleus in complex regional pain syndrome. Front Integr Neurosci (2012) 0.75
The noradrenergic locus coeruleus as a chronic pain generator. J Neurosci Res (2016) 0.75
Spinal cord stimulation modulates supraspinal centers of the descending antinociceptive system in rats with unilateral spinal nerve injury. Mol Pain (2015) 0.75
Central Sensitization-Based Classification for Temporomandibular Disorders: A Pathogenetic Hypothesis. Pain Res Manag (2017) 0.75
Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods (1994) 23.05
Ethical guidelines for investigations of experimental pain in conscious animals. Pain (1983) 17.70
An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain (1992) 9.17
Function and regulation of CREB family transcription factors in the nervous system. Neuron (2002) 7.99
Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain (2000) 6.21
Descending control of pain. Prog Neurobiol (2002) 6.20
Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell (2004) 6.08
The induction of pain: an integrative review. Prog Neurobiol (1999) 3.70
Chronic pain and medullary descending facilitation. Trends Neurosci (2002) 3.54
Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat. Neurosci Lett (1991) 2.32
Noradrenergic pain modulation. Prog Neurobiol (2006) 2.28
Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J Neurosci (2002) 2.00
Descending modulation in persistent pain: an update. Pain (2002) 1.92
Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci U S A (1999) 1.89
Using c-fos as a neural marker of pain. Brain Res Bull (1998) 1.88
Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial. J Clin Psychiatry (2007) 1.84
Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J Neurosci (2001) 1.72
Fos, nociception and the dorsal horn. Prog Neurobiol (2005) 1.65
A quantitative and morphological study of projection neurons in lamina I of the rat lumbar spinal cord. Eur J Neurosci (2003) 1.46
Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitization. Neuroscience (2006) 1.39
Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci (2000) 1.33
Cognitive strategy-specific increases in phosphorylated cAMP response element-binding protein and c-Fos in the hippocampus and dorsal striatum. J Neurosci (2003) 1.25
Patterns of increased brain activity indicative of pain in a rat model of peripheral mononeuropathy. J Neurosci (1993) 1.23
Neuronal lesioning with axonally transported toxins. J Neurosci Methods (2000) 1.19
Central noradrenergic lesioning using anti-DBH-saporin: anatomical findings. Brain Res (1996) 1.18
Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation. J Neurosci (2003) 1.11
The origin of brainstem noradrenergic and serotonergic projections to the spinal cord dorsal horn in the rat. Somatosens Mot Res (1992) 1.10
Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats. Neurosci Lett (1996) 1.09
Influence of peripheral nerve injury on response properties of locus coeruleus neurons and coeruleospinal antinociception in the rat. Neuroscience (2007) 1.04
Differential effects of neurotoxic destruction of descending noradrenergic pathways on acute and persistent nociceptive processing. Pain (1999) 1.03
Long-term effects of decreased noradrenergic central nervous system innervation on pain behavior and opioid antinociception. J Comp Neurol (2003) 1.02
Basal and touch-evoked fos-like immunoreactivity during experimental inflammation in the rat. Pain (1996) 1.00
The locus coeruleus in the rat: an immunohistochemical delineation. Neuroscience (1980) 1.00
The use of local anaesthetic microinjections to identify central pathways: a quantitative evaluation of the time course and extent of the neuronal block. Exp Brain Res (1987) 1.00
Attenuation of capsaicin-evoked mechanical allodynia by peripheral neuropeptide Y Y1 receptors. Pain (2006) 0.99
Descending projections of the locus coeruleus and subcoeruleus/medial parabrachial nuclei in monkey: axonal transport studies and dopamine-beta-hydroxylase immunocytochemistry. Brain Res (1980) 0.99
Intrathecal neuropeptide Y reduces behavioral and molecular markers of inflammatory or neuropathic pain. Pain (2007) 0.99
The neurobiology of persistent pain and its clinical implications. Suppl Clin Neurophysiol (2004) 0.98
Microinjection of morphine in the A7 catecholamine cell group produces opposing effects on nociception that are mediated by alpha1- and alpha2-adrenoceptors. Neuroscience (1999) 0.97
Peripheral nerve injury-induced changes in spinal alpha(2)-adrenoceptor-mediated modulation of mechanically evoked dorsal horn neuronal responses. J Pain (2008) 0.96
The function of noradrenergic neurons in mediating antinociception induced by electrical stimulation of the locus coeruleus in two different sources of Sprague-Dawley rats. Brain Res (1993) 0.96
A method of reversible inactivation of small regions of brain tissue. J Neurosci Methods (1979) 0.95
Quantitative characterization of ceruleospinal inhibition of nociceptive transmission in the rat. J Neurophysiol (1986) 0.95
Spinal noradrenergic activation mediates allodynia reduction from an allosteric adenosine modulator in a rat model of neuropathic pain. Pain (2002) 0.93
Are there long-term changes in the basal or evoked Fos expression in the dorsal horn of the spinal cord of the mononeuropathic rat? Pain (1999) 0.93
Unilateral hindpaw inflammation induces bilateral activation of the locus coeruleus and the nucleus subcoeruleus in the rat. Brain Res Bull (2003) 0.91
Bidirectional modulation of nociception by GABA neurons in the dorsolateral pontine tegmentum that tonically inhibit spinally projecting noradrenergic A7 neurons. Neuroscience (2000) 0.91
In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody. Cancer Res (1990) 0.90
Neuropeptide Y acts at Y1 receptors in the rostral ventral medulla to inhibit neuropathic pain. Pain (2007) 0.90
The role of ascending neuronal pathways in stress-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats. J Neuroendocrinol (1999) 0.89
Spinal pathways mediating tonic, coeruleospinal, and raphe-spinal descending inhibition in the rat. J Neurophysiol (1987) 0.89
Descending modulation from the region of the locus coeruleus on nociceptive sensitivity in a rat model of inflammatory hyperalgesia. Brain Res (1996) 0.88
The expression of saporin, a ribosome-inactivating protein from the plant Saponaria officinalis, in Escherichia coli. J Biol Chem (1993) 0.88
Nerve injury-induced tactile allodynia is present in the absence of FOS labeling in retrogradely labeled post-synaptic dorsal column neurons. Pain (2006) 0.87
Nociceptive stimulation activates locus coeruleus neurones projecting to the somatosensory thalamus in the rat. J Physiol (2005) 0.86
Sex-dependent effects of restraint on nociception and pituitary-adrenal hormones in the rat. Physiol Behav (1994) 0.85
Brainstem noradrenergic control of nociception is abnormal in the spontaneously hypertensive rat. Neurosci Lett (2000) 0.85
Characterization of descending modulation of nociception from the A5 cell group. Brain Res (1991) 0.83
Central noradrenergic blockade prevents autotomy in rat: implication for pharmacological prevention of postdenervation pain syndrome. Brain Res Bull (2002) 0.83
Coeruleospinal inhibition of nociceptive processing in the dorsal horn during unilateral hindpaw inflammation in the rat. Pain (2003) 0.83
Bilateral lesions in the area of the nucleus locus coeruleus affect the development of hyperalgesia during carrageenan-induced inflammation. Brain Res (1996) 0.83
Association of spinal lamina I projections with brainstem catecholamine neurons in the monkey. Exp Brain Res (1996) 0.82
The challenge of chronic pain. Adv Drug Deliv Rev (2003) 0.82
A feedback-controlled dynamic linear actuator to test foot withdrawal thresholds in rat. J Neurosci Methods (2007) 0.81
Noradrenergic lesioning with an anti-dopamine beta-hydroxylase immunotoxin. Brain Res (1994) 0.80
Pharmacological profile of the potentiation of opioid analgesia by restraint stress. Pharmacol Biochem Behav (1990) 0.80
Activation of coeruleospinal noradrenergic inhibitory controls during withdrawal from morphine in the rat. J Neurosci (1998) 0.79
Alterations in nociception following lesions of the A5 catecholamine nucleus. Brain Res (1986) 0.79
The potentiating effects of restraint stress and continuous naloxone infusion on the analgesic potency or morphine are additive. Brain Res (1993) 0.76
Partial isolation of two classes of dopamine beta-hydroxylase-containing particles undergoing rapid axonal transport in rat sciatic nerve. J Neurochem (1989) 0.76
Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence. Science (2013) 1.91
PPARγ activation blocks development and reduces established neuropathic pain in rats. Neuropharmacology (2013) 1.00
Intrathecal neuropeptide Y reduces behavioral and molecular markers of inflammatory or neuropathic pain. Pain (2007) 0.99
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. Neuropharmacology (2009) 0.91
The effects of prior chronic stress on cardiovascular responses to acute restraint and formalin injection. Brain Res (1998) 0.86
The differential contribution of capsaicin-sensitive afferents to behavioral and cardiovascular measures of brief and persistent nociception and to Fos expression in the formalin test. Brain Res (1997) 0.85
Blockade of micro-opioid receptors in the medial thalamus inhibits acquisition, but not expression, of morphine-induced conditioned place preference. Neuroscience (2007) 0.83
Y1 receptor knockout increases nociception and prevents the anti-allodynic actions of NPY. Nutrition (2008) 0.82
Topography and time course of changes in spinal neuropeptide Y immunoreactivity after spared nerve injury. Neuroscience (2009) 0.81
Distraction reduces self-reported physiological reactions to blood donation in novice donors with a blunting coping style. Psychosom Med (2001) 0.80
Overexpression of neurotrophin-3 in skeletal muscle alters normal and injury-induced limb control. Somatosens Mot Res (2001) 0.79
Mechanisms and pharmacology of neuropathic pain in multiple sclerosis. Curr Top Behav Neurosci (2014) 0.76
Twos-complement data processing for improved encoded matrix-vector processors. Appl Opt (1986) 0.75
Macrophage conditioned media affects steroid hormone production by placental cultures. Ann Clin Lab Sci (1995) 0.75
Physiological responses to child abuse stimuli as criteria for selection of hotline counselors. J Gen Psychol (1981) 0.75
Peripheral beta adrenergic blockade modifies airpuff startle-induced heart rate responses. J Pharmacol Exp Ther (1995) 0.75
Banded-matrix high-performance algorithm and architecture. Appl Opt (1985) 0.75
Error-source effects in a high-accuracy optical finite-element processor. Appl Opt (1986) 0.75